Examining the 2022 national drug control strategy and the federal response to the overdose crisis : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, second session, June 27, 2022.

Author/creator United States
Format Electronic
PublicationWashington : U.S. Government Publishing Office, 2022.
Description1 online resource (iii, 35 pages)
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo184890
Subjects

General noteAccess ID (govinfo): CHRG-117hhrg47929.
General note"Serial no. 117-90."
General noteGPO Cataloging Record Distribution Program (CRDP).
Performer Hearing witnesses: Dr. Rahul Gupta, Director, Office of National Drug Control Policy, Executive Office of the President.
Date/time/place of a event noteDate of hearing: 2022-06-27.
Source of descriptionDescription based on online resource; title from PDF title page (govinfo, viewed July 28, 2022).
Issued in other formPrint version: United States. Congress. House. Committee on Oversight and Reform. Examining the 2022 national drug control strategy and the federal response to the overdose crisis
Genre/formLegislative hearings.
Standard identifier# 47-929 (GPO jacket number)
Technical rpt numberSerial no. 117-90 (United States. Congress. House. Committee on Oversight and Reform)
GPO item number1016-C (online)
Govt. docs number Y 4.OV 2:117-90

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available